HEALTH CATALYST INC's ticker is HCAT and the CUSIP is 42225T107. A total of 155 filers reported holding HEALTH CATALYST INC in Q2 2023. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $139 | -72.5% | 21,806 | -67.5% | 0.00% | -75.0% |
Q1 2024 | $506 | -4.9% | 67,134 | +16.8% | 0.00% | +33.3% |
Q4 2023 | $532 | -22.9% | 57,490 | -15.7% | 0.00% | -57.1% |
Q3 2023 | $690 | -15.8% | 68,197 | +4.1% | 0.01% | 0.0% |
Q2 2023 | $819 | -67.2% | 65,527 | -69.3% | 0.01% | -66.7% |
Q1 2023 | $2,494 | +53.8% | 213,703 | +40.1% | 0.02% | -12.5% |
Q4 2022 | $1,622 | -99.9% | 152,579 | +8.2% | 0.02% | +33.3% |
Q3 2022 | $1,368,000 | +222.6% | 140,991 | +382.0% | 0.02% | +260.0% |
Q2 2022 | $424,000 | -76.1% | 29,250 | -56.9% | 0.01% | -77.3% |
Q1 2022 | $1,775,000 | +140.5% | 67,924 | +264.8% | 0.02% | +175.0% |
Q4 2021 | $738,000 | +17.1% | 18,619 | +47.7% | 0.01% | -11.1% |
Q3 2021 | $630,000 | +135.1% | 12,603 | +37.1% | 0.01% | +28.6% |
Q2 2020 | $268,000 | +27.6% | 9,195 | +14.7% | 0.01% | -41.7% |
Q1 2020 | $210,000 | – | 8,018 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Daventry Group, LP | 2,247,053 | $14,358,669 | 6.41% |
First Light Asset Management, LLC | 3,956,089 | $25,279,409 | 2.22% |
Nepsis Inc. | 1,253,080 | $8,007,181 | 2.16% |
Granahan Investment Management | 1,042,733 | $6,663,064 | 0.27% |
Invenomic Capital Management LP | 850,581 | $5,435,213 | 0.26% |
PIER 88 INVESTMENT PARTNERS LLC | 130,240 | $832,234 | 0.19% |
ClariVest Asset Management LLC | 285,627 | $1,825,156 | 0.19% |
KENNEDY CAPITAL MANAGEMENT LLC | 1,274,844 | $8,146,253 | 0.17% |
CVS HEALTH Corp | 32,273 | $206,221 | 0.10% |
Olympiad Research LP | 18,987 | $121,327 | 0.09% |